SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001447028-21-000021
Filing Date
2021-03-04
Accepted
2021-03-04 16:32:42
Documents
90
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 10-K abus-20201231.htm   iXBRL 10-K 1869416
2 EX-4.2 exhibit42descriptionofsecu.htm EX-4.2 19444
3 EXHIBIT 21.1 exhibit211_listingofsubsid.htm EX-21.1 3254
4 EX-23.1 exhibit231_eyconsent2020.htm EX-23.1 6995
5 EX-31.1 exhibit311_10-kcertceo2020.htm EX-31.1 11757
6 EX-31.2 exhibit312_10-kcertcfo2020.htm EX-31.2 11834
7 EX-32.1 exhibit321_soxcertceo2020.htm EX-32.1 5805
8 EX-32.2 exhibit322_soxcertcfo2020.htm EX-32.2 5771
14 abus-20201231_g1.jpg GRAPHIC 1529511
15 abus-20201231_g2.jpg GRAPHIC 60849
  Complete submission text file 0001447028-21-000021.txt   12752873

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT abus-20201231.xsd EX-101.SCH 59724
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT abus-20201231_cal.xml EX-101.CAL 97845
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT abus-20201231_def.xml EX-101.DEF 387864
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT abus-20201231_lab.xml EX-101.LAB 704745
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT abus-20201231_pre.xml EX-101.PRE 531686
16 EXTRACTED XBRL INSTANCE DOCUMENT abus-20201231_htm.xml XML 1321833
Mailing Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8
Business Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8 604-419-3200
Arbutus Biopharma Corp (Filer) CIK: 0001447028 (see all company filings)

IRS No.: 980597776 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-34949 | Film No.: 21714605
SIC: 2834 Pharmaceutical Preparations